HPV Testing And Pap Test Market Growth Outlook Indicating Expansion To $8.59 Billion By 2030

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The HPV Testing And Pap Test Market Increase Between 2026 And 2030?

The market size for hpv testing and pap test has experienced rapid expansion in recent years. It is anticipated to increase from $4.83 billion in 2025 to $5.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The growth observed in the past can be attributed to the broadening of cervical cancer screening programs, increasing awareness of women’s health matters, greater acceptance of pap testing, the development of diagnostic laboratory networks, and the availability of standardized screening protocols.

The hpv testing and pap test market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach $8.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. Factors driving this growth during the forecast timeframe include the rising adoption of molecular diagnostic technologies, heightened demand for early cancer detection, the proliferation of population-based screening programs, the expanding utilization of automated laboratory systems, and increased healthcare investments dedicated to preventive diagnostics. Key trends anticipated within this period encompass the increasing acceptance of HPV DNA-based screening tests, a greater reliance on liquid-based cytology techniques, the broader integration of automated diagnostic platforms, the expansion of co-testing strategies for cervical screening, and an intensified focus on improving the accuracy of early cancer detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10060&type=smp

What Important Drivers Are Powering The HPV Testing And Pap Test Market Growth?

The escalating incidence of cervical cancer is propelling the HPV testing and Pap test markets. Cervical cancer is characterized by the uncontrolled proliferation of cells within the cervix. This increase in cervical cancer prevalence is primarily attributed to a lack of consistent screening, which impedes the early identification and timely intervention for precancerous changes. Managing the rising cases of cervical cancer is achievable through early detection, which can be accomplished via HPV testing and Pap tests. For instance, in May 2025, the Cancer Council Australia, an Australia-based national nonprofit organization, reported that in 2023, 231 females in Victoria were diagnosed with invasive cervical cancer, representing a current diagnosis rate of 6.4 cases per 100,000 females. Thus, the growing prevalence is stimulating the expansion of the HPV testing and Pap test market.

How Does Segment Analysis Break Down The HPV Testing And Pap Test Market Structure?

The hpv testing and pap test market covered in this report is segmented –

1) By Test Type: HPV Testing, Pap Test

2) By Product: Instruments, Consumables, Services

3) By End User: Hospitals And Clinics, Laboratories, Other End Users

Subsegments:

1) By HPV Testing: High-Risk HPV Testing, HPV Genotyping

2) By Pap Test: Conventional Pap Test, Liquid-Based Pap Test, Pap Plus HPV Testing

What Trends Are Influencing The HPV Testing And Pap Test Market Outlook?

Leading firms within the HPV and Pap test market are concentrating on creating advanced options, including swift, economical, and point-of-care screening kits, aimed at enhancing the early detection and availability of cervical cancer tests. These rapid, low-cost, point-of-care screening kits are diagnostic tools designed to provide fast outcomes, remain budget-friendly, and be deployed directly in clinical or community environments, bypassing the need for sophisticated lab facilities. An illustrative example is from April 2025, when the Department of Biotechnology, an India-based government agency, introduced HPV test kits for cervical cancer screening. These specific kits facilitate quick, on-site identification of high-risk HPV genotypes, which are implicated in more than 96% of cervical cancer incidents, thereby permitting quicker and more precise screening processes. They are cost-effective and engineered for application in areas with limited resources, thus promoting broad availability across both rural and urban healthcare establishments. Such kits contribute to India’s initiatives for preventing cervical cancer by presenting an economical substitute to conventional screening approaches, aligning with the WHO’s objective of achieving 70% screening coverage by 2030.

Which Firms Are Competing In The HPV Testing And Pap Test Market?

Major companies operating in the hpv testing and pap test market are Abbott Laboratories, QIAGEN N V, Becton Dickinson and Company, Hologic Inc, F Hoffmann La Roche AG, Seegene Inc, DiaSorin S p A, Genomica S A U, TruScreen Group Limited, Danaher Corporation, Siemens Healthineers AG, bioMérieux SA, Takara Bio Inc, Fujirebio Diagnostics Inc, Randox Laboratories Ltd, Quidel Corporation, Vela Diagnostics, Greiner Bio One International GmbH, Cepheid, Roche Diagnostics International AG, Genedrive plc

Access The Complete HPV Testing And Pap Test Market Report:

https://www.thebusinessresearchcompany.com/report/hpv-testing-and-pap-test-global-market-report

Which Region Is The Primary Market For The HPV Testing And Pap Test Market?

North America was the largest region in the HPV testing and Pap test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global HPV testing and Pap tests market report during the forecast period. The regions covered in the hpv testing and pap test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a HPV Testing And Pap Test Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/hpv-testing-and-pap-test-global-market-report

Browse Through More Reports Similar to the Global HPV Testing And Pap Test Market 2026, By The Business Research Company

Human Papillomavirus Hpv Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-papillomavirus-hpv-vaccine-global-market-report

Hpv Associated Disorders Market Report 2026

https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

Cervical Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795